X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21447) 21447
Book Review (5088) 5088
Publication (1732) 1732
Newsletter (460) 460
Book Chapter (150) 150
Conference Proceeding (71) 71
Dissertation (23) 23
Book / eBook (22) 22
Magazine Article (11) 11
Reference (4) 4
Trade Publication Article (3) 3
Data Set (1) 1
Newspaper Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18550) 18550
animals (11629) 11629
male (10126) 10126
humans (9923) 9923
rats (6941) 6941
angiotensin (5574) 5574
hypertension (5277) 5277
female (4852) 4852
blood pressure - drug effects (3897) 3897
pharmacology & pharmacy (3775) 3775
angiotensin-ii (3165) 3165
angiotensin ii (3139) 3139
peripheral vascular disease (2848) 2848
hypertension - drug therapy (2821) 2821
renin-angiotensin system (2763) 2763
physiology (2676) 2676
middle aged (2664) 2664
blood-pressure (2656) 2656
angiotensin-converting enzyme inhibitors - therapeutic use (2620) 2620
cardiac & cardiovascular systems (2513) 2513
blood pressure (2454) 2454
rats, sprague-dawley (2426) 2426
angiotensin ii - pharmacology (2408) 2408
aged (2213) 2213
angiotensin receptor antagonists (2139) 2139
mice (2075) 2075
hypertension - physiopathology (1901) 1901
adult (1879) 1879
losartan (1861) 1861
research (1814) 1814
renin-angiotensin system - drug effects (1808) 1808
abridged index medicus (1802) 1802
antihypertensive agents - therapeutic use (1749) 1749
dose-response relationship, drug (1740) 1740
heart failure (1716) 1716
angiotensin-converting enzyme inhibitors - pharmacology (1671) 1671
rats, wistar (1646) 1646
oxidative stress (1565) 1565
urology & nephrology (1551) 1551
physiological aspects (1541) 1541
expression (1491) 1491
treatment outcome (1483) 1483
disease models, animal (1442) 1442
antihypertensive agents - pharmacology (1433) 1433
rodents (1433) 1433
tetrazoles - pharmacology (1404) 1404
drug therapy (1390) 1390
medicine & public health (1384) 1384
drug therapy, combination (1364) 1364
risk factors (1351) 1351
analysis (1282) 1282
time factors (1275) 1275
renin-angiotensin system - physiology (1262) 1262
endocrinology & metabolism (1240) 1240
enzymes (1239) 1239
ace inhibitors (1220) 1220
angiotensin ii - metabolism (1219) 1219
neurosciences (1191) 1191
heart failure - drug therapy (1184) 1184
mortality (1181) 1181
angiotensin ii type 1 receptor blockers - pharmacology (1175) 1175
angiotensin-converting enzyme inhibitors - administration & dosage (1127) 1127
health aspects (1116) 1116
angiotensin ii type 1 receptor blockers - therapeutic use (1113) 1113
renin (1088) 1088
losartan - pharmacology (1085) 1085
angiotensin-converting enzyme (1082) 1082
diabetes (1063) 1063
nitric oxide (1061) 1061
aldosterone (1050) 1050
heart-failure (1042) 1042
cardiology (1036) 1036
system (1035) 1035
antihypertensive agents - administration & dosage (1009) 1009
nitric-oxide (1007) 1007
imidazoles - pharmacology (1002) 1002
care and treatment (989) 989
heart rate - drug effects (985) 985
receptor (984) 984
inflammation (977) 977
receptors (969) 969
inhibition (968) 968
kidney - drug effects (962) 962
biochemistry & molecular biology (940) 940
fibrosis (933) 933
tetrazoles - therapeutic use (901) 901
blood pressure - physiology (891) 891
internal medicine (874) 874
heart (872) 872
myocardial-infarction (870) 870
brain (861) 861
article (859) 859
medicine, research & experimental (859) 859
rat (857) 857
kidney (849) 849
angiotensin ii - physiology (844) 844
rats, inbred shr (826) 826
valsartan (821) 821
captopril (818) 818
medicine, general & internal (808) 808
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21718) 21718
Japanese (83) 83
German (75) 75
French (44) 44
Russian (35) 35
Spanish (22) 22
Chinese (16) 16
Portuguese (16) 16
Hungarian (9) 9
Danish (8) 8
Polish (7) 7
Norwegian (5) 5
Ukrainian (5) 5
Swedish (4) 4
Italian (3) 3
Czech (2) 2
Hebrew (2) 2
Korean (2) 2
Bosnian (1) 1
Dutch (1) 1
Finnish (1) 1
Lithuanian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Disease prevention | Prescription drugs | Drug therapy | Meta-analysis | Index Medicus | Abridged Index Medicus | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2009, Volume 20, Issue 12, pp. 2641 - 2650
Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy. Most human studies testing the... 
PRONE HYPERTENSIVE-RATS | VASCULAR INJURY | CONTROLLED-TRIAL | CARDIOVASCULAR OUTCOMES | ALDOSTERONE ANTAGONISM | HEART-FAILURE | RENAL OUTCOMES | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | CHRONIC KIDNEY-DISEASE | ANTIHYPERTENSIVE TREATMENT | Angiotensin II Type 1 Receptor Blockers - adverse effects | Spironolactone - administration & dosage | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Diabetic Nephropathies - physiopathology | Lisinopril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Bicarbonates - blood | Blood Pressure - drug effects | Albuminuria - urine | Drug Therapy, Combination | Hypertension - urine | Spironolactone - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Lisinopril - administration & dosage | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Double-Blind Method | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Hypertension - physiopathology | Albuminuria - drug therapy | Losartan - adverse effects | Potassium - blood | Renin-Angiotensin System - drug effects | Losartan - administration & dosage | Index Medicus | Clinical Research
Journal Article
European Heart Journal, ISSN 0195-668X, 10/2015, Volume 36, Issue 38, pp. 2576 - 2584
Journal Article
The Laryngoscope, ISSN 0023-852X, 07/2015, Volume 125, Issue 7, pp. 1619 - 1623
Journal Article
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1368, pp. 231 - 238
Abstract Sleep apnea is characterized by increased sympathetic activity and is associated with systemic hypertension. Angiotensin (Ang) peptides have... 
Neurology | Intermittent hypoxia | Hypertension | Renin–angiotensin system | Sympathetic activity | Angiotensin-(1–7) | Renin-angiotensin system | Angiotensin-(1-7) | HEART-FAILURE | AWAKE RATS | CHEMOREFLEX ACTIVATION | NEUROSCIENCES | BLOOD-PRESSURE | CHRONIC-INTERMITTENT HYPOXIA | CARDIOVASCULAR REGULATION | ROSTRAL VENTROLATERAL MEDULLA | SYMPATHETIC-NERVE ACTIVITY | NITRIC-OXIDE | EPISODIC HYPOXIA | Sleep Apnea Syndromes - physiopathology | Angiotensin II - administration & dosage | Angiotensin Receptor Antagonists - pharmacology | Imidazoles - administration & dosage | Male | Peptide Fragments - pharmacology | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 2 Receptor Blockers - pharmacology | Hypertension - etiology | Hypertension - prevention & control | Blood Pressure - drug effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Disease Models, Animal | Angiotensin II - pharmacology | Pyridines - administration & dosage | Microinjections | Peptide Fragments - administration & dosage | Losartan - pharmacology | Rats | Imidazoles - pharmacology | Angiotensin II - analogs & derivatives | Rats, Sprague-Dawley | Sleep Apnea Syndromes - complications | Paraventricular Hypothalamic Nucleus - drug effects | Animals | Angiotensin II Type 2 Receptor Blockers - administration & dosage | Pyridines - pharmacology | Losartan - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Index Medicus | Neurons | Carbon dioxide | Antagonists | Hypothalamus | Paraventricular nucleus | Muscimol | Sympathetic nervous system | Telemetry | Angiotensin receptors | Sleep disorders | Apnea | gamma -Aminobutyric acid A receptors | Angiotensin | Hypoxia | Blood pressure | cardiovascular regulation | peptides: anatomy and physiology | sympathetic activity | angiotensin-(1-7) | hypothalamic-pituitary-adrenal regulation | intermittent hypoxia | hypertension | renin-angiotensin system
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 04/2017, Volume 38, Issue 15, pp. 1132 - 1143
Background Compared to heart failure patients with higher systolic blood pressure (SBP), those with lower SBP have a worse prognosis. To make matters worse,... 
Heart failure | TRIAL | AT1-receptor | NEPRILYSIN INHIBITION | CARDIAC & CARDIOVASCULAR SYSTEMS | Angiotensin | Neprilysin | Blood pressure | ENALAPRIL | Valsartan - administration & dosage | Humans | Aminobutyrates - adverse effects | Male | Death, Sudden, Cardiac - etiology | Enalapril - adverse effects | Dose-Response Relationship, Drug | Hypotension - mortality | Tetrazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Blood Pressure - drug effects | Aminobutyrates - administration & dosage | Drug Therapy, Combination | Enalapril - administration & dosage | Heart Failure - mortality | Drug Administration Schedule | Stroke Volume - physiology | Valsartan - adverse effects | Treatment Outcome | Hospitalization | Hypotension - chemically induced | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Heart Failure - drug therapy | Neprilysin - antagonists & inhibitors | Aged | Tetrazoles - adverse effects | Chronic Disease | Angiotensin Receptor Antagonists - administration & dosage | Angiotensin Receptor Antagonists - adverse effects | Index Medicus | Clinical Research | Editor's Choice | Kardiologi | Cardiac and Cardiovascular Systems | enalapril heart failure | chronic hypotension systolic blood pressure heart failure blood pressure cardiovascular system safety ejection fraction cardiovascular death sacubitril / valsartan
Journal Article
Diabetes, ISSN 0012-1797, 01/2015, Volume 64, Issue 1, pp. 236 - 242
Journal Article